20 Amendments of Michèle RIVASI related to 2011/0339(COD)
Amendment 27 #
Proposal for a regulation
Title
Title
Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on establishing a Health for Growth Programme, the third multi- annual programme of EU action in the field of health for the period 2014-2020 (This amendment applies throughout the text. Adopting it will necessitate corresponding changes throughout.)
Amendment 36 #
Proposal for a regulation
Recital 2
Recital 2
(2) Continued effort is required in order to meet the requirements set out in Article 168 of the Treaty. Promoting good health at EU level is an integral part of the ‘EurKeeping people 2020: A European Strategy for smart, sustainable and inclusive growth’. Keeping people healthy and active for longer will have positive overall health effects, and a positive impact on productivity and competitivenesshealthy, both physically and mentally, and active for longer will be of major benefit to people individually as well as to society as a whole, while reducing pressures on national budgets. Innovation in health helps take up the challenge of sustainability in the sector in the context of demographic change, and action to reduce inequalities in health is important to achieve ‘inclusive growth’the fundamental value of ‘equality’ as laid down in Article 2 of the Treaty on European Union. It is appropriate in this context to establish a ‘Health for Growth’ Programme, the third programme of EU action on health (2014- 2020) (hereinafter referred to as ‘the Programme’).
Amendment 52 #
Proposal for a regulation
Recital 10
Recital 10
(10) In the context of an ageing society, well-directed investments to promote health and prevent diseases can increase the number of ‘healthy life years’ and thus enable the elderly to continue working as they grow older. Chronic diseases are responsible for over 80% of premature mortality in the EU. By identifying, disseminating and promoting the up-take of validated best practices for cost-effective prevention measures focused on the key risk factors, namely smoking, abuse of alcohol and obesity, as well as on HIV/AIDS, an unhealthy diet, a sedentary lifestyle, and obesity, illegal drugs, improper use of pharmaceuticals, risky sexual behaviour, as well as social and environmental factors, the Programme will contribute to preventing diseases and promote good health, also bearing in mind underlying factors of a social and environmental nature, particularly those causing deterioration or loss of physical or mental function, and promote good health.
Amendment 65 #
Proposal for a regulation
Recital 11
Recital 11
(11) To minimise the public health consequences of cross-border health threats which could range from mass contamination caused by chemical incidents to pandemics, like those unleashed recently by E coli, influenza strain H1N1 or SARS (severe acute respiratory syndrome), the Programme should contribute to the creation and maintenance of robust mechanisms and tools to detect, assess and manage major cross-border health threats. Due to the nature of these threats, the Programme should support coordinated public health measures at EU level to address different aspects, building on preparedness and response planning, robust and reliable risk assessment and a strong risk and crisis management framework. In this context, it is important that the programme should benefit from complementarity with the work programme of the European Centre for Disease Prevention and Control in the fight against communicable diseases and the activities supported under the Unions programmes for research and innovation. Special efforts should be undertaken to ensure coherence and synergies between the Programme and global health work carried out under other Community programmes and instruments that address in particular the areas of influenza, HIV/AIDS, tuberculosis and other cross- border health threats in third countries. Action under the programme mayshould also cover cross-border threats to health caused by biological and chemical incidents, environment and climate change. As stated in the Commission's Communication ‘A Budget for Europe 2020’, the Commission has committed to mainstreaming climate change into overall Union spending programmes and to direct at least 20% of the Union budget to climate-related objectives. Spending in the Health for Growth Programme under objective 4 will contribute in a general manner to this objective by addressing health threats associated to climate change. The Commission will provide information on climate change expenditure within the Health for Growth Programme.
Amendment 71 #
Proposal for a regulation
Recital 15
Recital 15
(15) NIndependent non-governmental bodies and health stakeholders, in particular independent patients' organisations and health professionals' associations, play an important role in providing the Commission the information and advice necessary to implement the programme. In playing this role, they may require contributions from the Programme to enable them to function. That is why the programme shall be accessible to representative NGOs and patient organisations working in the public health area, which play an effective role in civil dialogue processes at EU level, such as for example participation in consultative groups, and in that way contribute to pursuing the Programme's specific objectives.
Amendment 73 #
Proposal for a regulation
Recital 15 a (new)
Recital 15 a (new)
(15a) The Programme should recognise the importance of a holistic approach to public health and take into account, where appropriate and where there is scientific or clinical evidence about its efficacy, complementary and alternative medicine in its actions.
Amendment 92 #
Proposal for a regulation
Article 3 – point 1 – paragraph 1
Article 3 – point 1 – paragraph 1
(1) To develop common tools and mechanisms at EU level to address shortages of resources, both human and financial, and to facilitate up-take of innovation in healthcare in order to contribute to innovative and sustainablesustainable and universal health systems.
Amendment 100 #
Proposal for a regulation
Article 3 – point 2 – paragraph 2
Article 3 – point 2 – paragraph 2
This objective will be measured in particular through the increase of number of health professionals using the expertise gathered through the European Reference Networks in the context of Directive 2011/24/EU on the application of patients' rights in cross- border healthcare (hereinafter referred to as ‘the European Reference Networks’); the increase of number of patients using these networks; and the increase of number of Member States using the developed guidelines. This objective will also be measured through the number of centres of expertise created; the uptake of best practice by health providers and health professionals on quality and safety; the reduction of the use of antimicrobials and of antimicrobial resistance; the level of implementation of relevant Union legislation; and how widely the results of the Programme have been disseminated.
Amendment 105 #
Proposal for a regulation
Article 3 – point 3 – paragraph 1
Article 3 – point 3 – paragraph 1
(3) To identify, disseminate and promote the up-take of validated best practices for cost-effective prevention measure by addressing the key risk factors, namely smoking, abuse of alcohol and obesity, as well as HIV/AIDS, unhealthy diet, a sedentary lifestyle and obesity, illegal drugs, improper use of pharmaceuticals, risky sexual behaviour, as well as social and environmental factors, with a focus on the cross border dimension, in order to prevent diseases and promote good physical and mental health.
Amendment 170 #
Proposal for a regulation
Article 8 – paragraph 1
Article 8 – paragraph 1
1. The grants for actions referred to under Article 7 (2) (a) and (b) may be awarded to legally established organisations, public authorities, public sector bodies, in particular research and health institutions, universities and higher education establishments and undertakings. The beneficiaries shall be independent of industry, commercial and business or other conflicting interests.
Amendment 174 #
Proposal for a regulation
Article 8 – paragraph 2 – point c
Article 8 – paragraph 2 – point c
(c) They are active at the Union level and in at least half of the Member States, and have a balanced geographical coverage of the Union, or they are active at the Union level and in at least a quarter of the Member States, and commit to becoming active in at least half of the Member States and have a balanced geographical coverage of the Union within 3 years.
Amendment 177 #
Proposal for a regulation
Article 11 – paragraph 1 – point b
Article 11 – paragraph 1 – point b
(b) detailed eligibility criteria for the beneficiaries in compliance with Article 8, in particular concerning legal independence, financial independence, transparency of the applicants' activities and funding and effective assessment of independence;
Amendment 183 #
Proposal for a regulation
Article 13 – paragraph 3 – subparagraph 1
Article 13 – paragraph 3 – subparagraph 1
No later than mid-2018, an evaluation report shall be established by the Commission on the achievement of the objectives of all the measures (at the level of results and impacts), the efficiency of the use of resources and its European added value, in view of a decision on the renewal, modification or suspension of the measures. The evaluation shall additionally address the scope for simplification, its internal and external coherence, the continued relevance of all objectives, as well as the contribution of the measures to the Union prioriachievement of the objectives of smart, sustainable and inclusive growthset out in Article 168 of the Treaty. It shall take into account evaluation results on the long- term impact of the predecessor programme.
Amendment 194 #
Proposal for a regulation
Annex 1 – point 1 – point 1.7 a (new)
Annex 1 – point 1 – point 1.7 a (new)
1.7a. Alternatives to patent monopolies: Assessment of Innovation Inducement Prizes for a variety of diseases, including cancer, HIV/AIDS and tuberculosis to address medical needs and Open Source Research to allow researchers to collaborate and share knowledge on medicine research;
Amendment 199 #
Proposal for a regulation
Annex 1 – point 2 – point 2.2
Annex 1 – point 2 – point 2.2
2.2. Rare diseases: support Member States, patient organisations and stakeholders by coordinated action at Union level in order to effectively help patients affected by rare diseases as well as emerging rare diseases. This includes creation of centres of expertise, reference networks (in compliance with point 2.1), information and registries for rare diseases based on the common criteria of accreditation.
Amendment 201 #
Proposal for a regulation
Annex 1 – point 2 – point 2.3
Annex 1 – point 2 – point 2.3
2.3. Quality and safety: strengthen collaboration on patient safety and quality of healthcare, including complementary and alternative medicine, through, inter alia, implementing the Council Recommendation on patient safety and the prevention and control of healthcare- associated infections; exchange best practice on complementary and alternative medicine; exchange best practice on quality assurance systems; develop guidelines and tools to promote patient safety and quality; increase the availability of information to patients on safety and quality, improve feedback and interaction between health providers and patients; support action to exchange knowledge and best practice on chronic diseases care, the response of health systems and research including development of European guidelines.
Amendment 205 #
Proposal for a regulation
Annex 1 – point 2 – point 2.4
Annex 1 – point 2 – point 2.4
2.4. Safety: improve the prudent use of antimicrobial agents in medicinal products and reduce the practices that increase antimicrobial resistance, including in the veterinary sector; reduce the burden of resistant infections and healthcare- associated infections and secure the availability of effective antimicrobials.
Amendment 209 #
Proposal for a regulation
Annex 1 – point 3 – introductory part
Annex 1 – point 3 – introductory part
3. Identifying, disseminating and promoting up-take of validated best practices for cost-effective prevention measure by addressing the key risk factors, namely smoking, abuse of alcohol, unhealthy diet, a sedentary lifestyle and obesity, as well as HIV/AIDSillegal drugs, improper use of pharmaceuticals, risky sexual behaviour, as well as social and environmental factors, with a focus on the cross border dimension, in order to prevent diseases and promote good physical and mental health
Amendment 214 #
Proposal for a regulation
Annex 1 – point 3 – point 3.1
Annex 1 – point 3 – point 3.1
3.1. Cost-effective promotion and prevention measures of communicable and non-communicable diseases: this will include actions towards the setting up of pan- European networks and partnerships engaging wide range of actors in communication, education and awareness raising actions on key health issues such as smoking prevention, abuse of alcohol, addressing obesityunhealthy eating and a sedentary lifestyle as part of addressing obesity, illegal drugs, improper use of pharmaceuticals, and risky sexual behaviour, with a focus on the cross-border dimension and on Member States with no or little action on these issues.
Amendment 221 #
Proposal for a regulation
Annex 1 – point 3 – point 3.2
Annex 1 – point 3 – point 3.2
3.2. Chronic diseases: support European cooperation and networking on preventing and improving the response to chronic diseases including cancer, by sharing knowledge, good practice, promoting education and developing joint activities on prevention. Cancer: follow-up, including with regard to environmental risk factors. Building on work already undertaken;: set up a European cancerhronic disease information system with comparable data; support cancerhronic disease screening, including voluntary accreditation mechanisms; support the development of European guidelines for prevention where major inequalities exist.; address the health effects of wider environmental determinants, including indoor air quality, exposure to toxic chemicals where not addressed by other Union initiatives, and socio-economic determinants